Pear Therapeutics

Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Pear Therapeutics headquartered in United States, North America, operates in the Software, Biotechnology, Pharmaceutical, mHealth, Therapeutics sector. The company focuses on Software and has secured $65.4B in funding across 160 round(s). With a team of 101-250 employees, Pear Therapeutics is actively contributing to advancements in Software. Their latest funding round, Venture Round - Pear Therapeutics, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.